Year: 2025
Type: article
Abstract: The integration of cardiology into oncology care begins with risk stratification [9].Patients are assessed based on their baseline cardiovascular risk, cancer treatment regimen, and preexisting conditions [10].Biomarkers such as troponins and natriuretic peptides, AbstractCardio-oncology is an emerging medical specialty that focuses on the intersection between cancer treatments and cardiovascular health.With significant improvements in cancer therapies, such as chemotherapy, targeted therapies, and immunotherapy, the survival rates for cancer patients have drastically increased.However, these treatments often come with unintended cardiovascular side effects, which can lead to conditions like heart failure, arrhythmias, and coronary artery disease.This growing field aims to better understand, prevent, and manage the cardiovascular complications that can arise during or after cancer treatment, ensuring a better quality of life for survivors.The implications of cardio-oncology are profound, as it not only addresses the long-term health of cancer patients but also requires a collaborative approach between oncologists and cardiologists to optimize treatment strategies and mitigate risks.
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4409219295